Delivery Order SPE2DB22D3501-SPE2DB26FTG45
- Not listed
- The Defense Logistics Agency awarded a $12,171.08 delivery order to AmerisourceBergen Drug Corp on September 5, 2025, for the supply of Actemra 162 mg/0.9 mL syringes. This is a firm fixed price, non-set-aside contract with a completion date of September 8, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical vendor for federal medical procurement, particularly...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,648.95 to AmerisourceBergen Drug Corp on October 27, 2025, for the supply of Actemra 400 mg/20 mL vials. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded to support federal medical procurement needs. The product will be delivered to the company's facility in Conshohocken, Pennsylvania, with an ultimate completion date of October 28, 2025. This delivery order is issued under...
- On September 19, 2025, the Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for $38,572.76 to supply Actemra 200 mg/10 mL vials. This non-set-aside, competitively awarded contract represents a firm fixed-price delivery order with an ultimate completion date of September 22, 2025. The pharmaceutical product will be delivered to the contractor's location in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate...
- The Defense Logistics Agency awarded a $16,368.22 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Actemra 400 mg/20 ml vials. This non-set-aside contract was executed on October 30, 2025, with an ultimate completion date of October 31, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical vendor...
- The Defense Logistics Agency awarded a $21,612.59 delivery order to AmerisourceBergen Drug Corp for the supply of Actemra 400 mg/20 mL vials. This competitively awarded, firm fixed-price contract was executed on October 28, 2025, with an ultimate completion date of October 29, 2025, and will be performed at the contractor's corporate headquarters in Conshohocken, Pennsylvania. The award represents a single delivery order issued under a larger contract vehicle rather than a standalone...
- The Defense Logistics Agency awarded a delivery order valued at $5,284.97 to AmerisourceBergen Drug Corp for the supply of Actemra 400 mg/20 ml vials. The contract, issued on August 8, 2025, with an ultimate completion date of August 11, 2025, utilizes firm fixed price pricing with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, performed the work at its corporate office location. This delivery order...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 14, 2025, for the supply of Actemra 400 mg/20 mL vials with a ceiling value of $16,140.74. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and maintains an ultimate completion date of October 15, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on August 12, 2025, for the supply of Actemra 162 mg/0.9 mL syringes valued at $4,594.53. This firm fixed-price, competitively awarded delivery order is funded by the Defense Logistics Agency's Medical Supply Chain, a defense-focused federal agency, and has an ultimate completion date of August 13, 2025. The award was made under no set-aside designation,...
- The Defense Logistics Agency awarded a $20,188.75 delivery order to AmerisourceBergen Drug Corp on September 19, 2025, for the supply of Actemra 400 mg/20 ml vials. This is a firm fixed price, non-set-aside contract with a completion date of September 22, 2025, and performance occurring at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX),...
- The Defense Logistics Agency awarded a $20,481.14 delivery order to AmerisourceBergen Drug Corp on May 8, 2025, for the supply of Actemra 400 mg/20 ml vials. This is a firm fixed price, non-set-aside contract with a completion date of May 9, 2025, and performance will be conducted at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a single transaction under AmerisourceBergen's broader pharmaceutical supply relationship with the federal...
- SPE2DB22D3501Indefinite Delivery Contract
- SPE2DB22D3501-SPE2DB26FTG45Delivery Order
The Defense Logistics Agency awarded a $5,597.56 delivery order to AmerisourceBergen Drug Corp on October 28, 2025, for the supply of Actemra 400 mg/20 mL vials. This competitively awarded, non-set-aside contract will be completed by October 29, 2025, with performance taking place at the contractor's corporate office location in Conshohocken, Pennsylvania. As a major pharmaceutical distributor and critical federal medical procurement vendor, AmerisourceBergen Drug Corp fulfills pharmaceutical and medical supply needs for the Defense Logistics Agency's Medical Supply Chain, which supports military and veteran healthcare systems. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. This prime contract vehicle enables the company to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally, including specialty medications, brand-name and generic drugs, vaccines, and medical devices across multiple therapeutic domains. The contract supports customers including the Defense Health Agency and U.S. Coast Guard, positioning AmerisourceBergen as a key provider within the Defense Logistics Agency's pharmaceutical procurement infrastructure.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.6k | 10/28/25 |